Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.

Phillips MB, Sobus JR, George BJ, Isaacs K, Conolly R, Tan YM.

Regul Toxicol Pharmacol. 2014 Aug;69(3):434-42. doi: 10.1016/j.yrtph.2014.05.008. Epub 2014 May 17.

PMID:
24845241
2.
3.

Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data.

Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2015 Dec;73(3):765-9. doi: 10.1016/j.yrtph.2015.11.001. Epub 2015 Nov 12.

PMID:
26577196
4.

Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria.

Kirman CR, Aylward LL, Blount BC, Pyatt DW, Hays SM.

J Expo Sci Environ Epidemiol. 2012 Jan-Feb;22(1):24-34. doi: 10.1038/jes.2011.37. Epub 2011 Oct 12.

PMID:
21989501
5.

Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.

St-Amand A, Werry K, Aylward LL, Hays SM, Nong A.

Toxicol Lett. 2014 Dec 1;231(2):126-34. doi: 10.1016/j.toxlet.2014.10.019. Epub 2014 Oct 17.

6.

Using a physiologically based pharmacokinetic model to link urinary biomarker concentrations to dietary exposure of perchlorate.

Yang Y, Tan YM, Blount B, Murray C, Egan S, Bolger M, Clewell H.

Chemosphere. 2012 Aug;88(8):1019-27. doi: 10.1016/j.chemosphere.2012.03.074. Epub 2012 Apr 20.

PMID:
22520969
7.

Environmental chemicals in people: challenges in interpreting biomonitoring information.

LaKind JS, Barraj L, Tran N, Aylward LL.

J Environ Health. 2008 May;70(9):61-4.

PMID:
18517157
8.

Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.

Boogaard PJ, Hays SM, Aylward LL.

Regul Toxicol Pharmacol. 2011 Feb;59(1):125-32. doi: 10.1016/j.yrtph.2010.09.015. Epub 2010 Oct 7.

PMID:
20933039
9.

Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.

Aylward LL, Kirman CR, Blount BC, Hays SM.

Regul Toxicol Pharmacol. 2010 Oct;58(1):33-44. doi: 10.1016/j.yrtph.2010.05.011. Epub 2010 Jun 1.

PMID:
20685286
10.

California biomonitoring data: Comparison to NHANES and interpretation in a risk assessment context.

Aylward LL, Seiber JN, Hays SM.

Regul Toxicol Pharmacol. 2015 Dec;73(3):875-84. doi: 10.1016/j.yrtph.2015.10.002. Epub 2015 Oct 23.

11.

Biomonitoring Equivalents for bisphenol A (BPA).

Krishnan K, Gagné M, Nong A, Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2010 Oct;58(1):18-24. doi: 10.1016/j.yrtph.2010.06.005. Epub 2010 Jun 10. Review.

PMID:
20541576
12.

Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals.

Aylward LL, Kirman CR, Schoeny R, Portier CJ, Hays SM.

Environ Health Perspect. 2013 Mar;121(3):287-94. doi: 10.1289/ehp.1205740. Epub 2012 Dec 11.

13.

Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.

Hays SM, Aylward LL.

Int J Hyg Environ Health. 2012 Feb;215(2):145-8. doi: 10.1016/j.ijheh.2011.09.011. Epub 2011 Dec 20.

PMID:
22192580
14.

Changes in epidemiologic associations with different exposure metrics: a case study of phthalate exposure associations with body mass index and waist circumference.

Christensen K, Sobus J, Phillips M, Blessinger T, Lorber M, Tan YM.

Environ Int. 2014 Dec;73:66-76. doi: 10.1016/j.envint.2014.07.010. Epub 2014 Aug 2.

PMID:
25090576
15.

SHEDS-HT: an integrated probabilistic exposure model for prioritizing exposures to chemicals with near-field and dietary sources.

Isaacs KK, Glen WG, Egeghy P, Goldsmith MR, Smith L, Vallero D, Brooks R, Grulke CM, Özkaynak H.

Environ Sci Technol. 2014 Nov 4;48(21):12750-9. doi: 10.1021/es502513w. Epub 2014 Oct 21.

PMID:
25222184
16.

Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.

Hays SM, Becker RA, Leung HW, Aylward LL, Pyatt DW.

Regul Toxicol Pharmacol. 2007 Feb;47(1):96-109. Epub 2006 Oct 6. Review.

PMID:
17030369
17.

Biomonitoring equivalents for deltamethrin.

Aylward LL, Krishnan K, Kirman CR, Nong A, Hays SM.

Regul Toxicol Pharmacol. 2011 Jul;60(2):189-99. doi: 10.1016/j.yrtph.2011.03.014. Epub 2011 Apr 3.

PMID:
21466827
18.

Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.

Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, Linton B.

J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. Review.

PMID:
11809004
19.

Drinking water contribution to aggregate perchlorate intake of reproductive-age women in the United States estimated by dietary intake simulation and analysis of urinary excretion data.

Mendez W, Dederick E, Cohen J.

J Expo Sci Environ Epidemiol. 2010 May;20(3):288-97. doi: 10.1038/jes.2009.50. Epub 2009 Sep 23.

PMID:
19773816
20.

Direct measurement of perchlorate exposure biomarkers in a highly exposed population: a pilot study.

English P, Blount B, Wong M, Copan L, Olmedo L, Patton S, Haas R, Atencio R, Xu J, Valentin-Blasini L.

PLoS One. 2011 Mar 4;6(3):e17015. doi: 10.1371/journal.pone.0017015.

Supplemental Content

Support Center